Funder: Cystic Fibrosis Research Institute
Due Dates (Anticipated): February 2027 (Full proposal) | November 2027 (Letter of Intent)
Funding Amounts: Up to $80,000 per year for two years; minimum of two awards annually
Summary: Seed funding for original basic and clinical cystic fibrosis research aimed at improved treatments or a cure.
Key Information: Open to U.S. research institutions; principal investigators must work in their labs.
Description
New Horizons is the nationwide research campaign of the Cystic Fibrosis Research Institute (CFRI), supporting promising new cystic fibrosis (CF) research at academic and hospital institutions. The program seeks research of the highest scientific quality, with particular emphasis on projects relevant to finding improved treatments or a cure for CF.
The awards provide seed funding for new lines of basic and clinical CF research with prospects of attracting future support from other sources, such as the National Institutes of Health. Projects should be original, probing, and/or pioneer a new approach to therapy or a cure. CFRI’s Research Advisory Committee reviews the two-year projects, with continued support tied to satisfactory scientific progress, financial reporting, and available funds relevant to the project’s goals.
